Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000930413-11-004659
Filing Date
2011-07-06
Accepted
2011-07-06 12:30:16
Documents
1
Period of Report
2011-07-01

Document Format Files

Seq Description Document Type Size
1 c66205_form4.html 4  
1 c66205_form4.xml 4 3734
  Complete submission text file 0000930413-11-004659.txt   5302
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Issuer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address
SALISBURY ROBERT C (Reporting) CIK: 0001185468 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-12957 | Film No.: 11952344